By doing a dual labeling of CXCR2 and Cd66b on breast cancer tissues, we observed that most of the CXCR2 positive cells match with CD66b-positive neutrophils, confirming that neutrophils express high levels of CXCR2 as previously described (Figure 4) [18]. This evidence concerns the gene CXCR2 and breast cancer.